The Analyst Landscape: 17 Takes On Tenet Healthcare
Portfolio Pulse from Benzinga Insights
Analysts' ratings for Tenet Healthcare (NYSE:THC) over the last quarter vary from bullish to bearish, with 17 analysts providing insights. The average 12-month price target is $155.59, reflecting a 14.78% increase from the previous target. Analysts from firms like UBS, Goldman Sachs, and Wells Fargo have raised their price targets, indicating positive sentiment. Tenet Healthcare has shown positive revenue growth and strong financial health, but faces challenges in debt management.
August 14, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts' ratings for Tenet Healthcare (NYSE:THC) show a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 14.78% to $155.59. Analysts from major firms have raised their price targets, indicating positive sentiment. Tenet Healthcare has shown positive revenue growth and strong financial health, but faces challenges in debt management.
The increase in the average 12-month price target and the positive sentiment from major analysts suggest a likely short-term price increase for Tenet Healthcare. However, the company's high debt-to-equity ratio poses a risk that investors should monitor.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100